This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Compare the pros and cons of zero based budgeting and traditional budgeting, featuring practical considerations for different financial situations.
28,655 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A long-running tariff regime faces a courtroom setback and a looming deadline. This week, policymakers weigh tougher ...
AI's rapid growth in 2026 is real, but the panic around job loss and market collapse is overblown. This report explai...
An affluent California couple in their 70s plans a major renovation. Months later, they confront a surprising, steep ...
The Hormuz crisis is now a farm and food story. The ICC warns that fertilizer shipments could stall, triggering harve...
Anthropic debuts Claude Tag, a Slack-enabled virtual employee that collaborates across channels to streamline team ta...
As July opens, traders are eyeing a quiet market mover. This unheralded sector sure has a track record of supporting ...
June card spending rose 6.3% year over year, with wage gains across all income groups. The latest bofa consumer chief...
A new study and a flood of expert commentary suggest that the common tactic of draining parental savings to boost aid...
A retiree discovered that a severance-heavy last paycheck can trigger a Medicare surcharge years later. This story ex...
This article breaks down MSGM earnings and what investors should watch in motorsport games. Learn how revenue streams...
AMD's growth story is gaining steam as data centers, AI workloads, and CPU/GPU innovations align. This guide breaks d...